FDA Drug Shortages

Current and Resolved Drug Shortages and Discontinuations Reported to FDA

Start Over | Back to Previous Screen

Synthetic Conjugated Estrogens B (Enjuvia) Tablets
Status: Discontinuation
»Therapeutic Categories: Reproductive

Expand all

Teva Pharmaceuticals (New 01/24/2017)

Company Contact Information:
800-545-8800

Presentation Posting Date Related Information
0.45mg (NDC 51285-0407-02) 01/24/2017 Teva has made a business decision to permanently discontinue Enjuvia® Tablets.
0.625mg (NDC 51285-0408-02) 01/24/2017 Teva has made a business decision to permanently discontinue Enjuvia® Tablets.
0.9mg (NDC 5128-50409-02) 01/24/2017 Teva has made a business decision to permanently discontinue Enjuvia® Tablets.
1.25mg (NDC 51285-0410-02) 01/24/2017 Teva has made a business decision to permanently discontinue Enjuvia® Tablets.
0.3mg (NDC 51285-0406-02) 01/24/2017 Teva has made a business decision to permanently discontinue Enjuvia® Tablets.

Note: If you need help accessing information in different file formats, see Instructions for Downloading Viewers and Players.
Language Assistance Available: Español | 繁體中文 | Tiếng Việt | 한국어 | Tagalog | Русский | العربية | Kreyòl Ayisyen | Français | Polski | Português | Italiano | Deutsch | 日本語 | فارسی | English